Can the ESPRIT results end the antiplatelet battle between neurologists and cardiologists?

Nature Clinical Practice Cardiovascular Medicine

Volumn 4, Issue 3, 2007, Pages 118-119

  Albers, Gregory W ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; DIPYRIDAMOLE;

ANGINA PECTORIS; AUSTRALIA AND NEW ZEALAND; BLEEDING DISORDER; CARDIOLOGIST; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG BLOOD LEVEL; DRUG EFFICACY; EUROPEAN UNION; HEADACHE; HEART DEATH; HEART DISEASE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; MEDICAL SPECIALIST; META ANALYSIS; MONOTHERAPY; NEUROLOGY; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SIDE EFFECT; SUDDEN DEATH; SYSTEMATIC REVIEW; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

CARDIOLOGY; CEREBROVASCULAR ACCIDENT; CLINICAL TRIALS; CORONARY DISEASE; HUMANS; NEUROLOGY; PLATELET AGGREGATION INHIBITORS; TREATMENT OUTCOME;

EID: 33847709540     PISSN: 17434297     EISSN: 17434300     Source Type: Journal    
DOI: 10.1038/ncpcardio0803     Document Type: Review

References (10)

1. Sacco RL et al. (2006) Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: A statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: Co-sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Stroke 37: 577-617
2. Halkes PH et al. for The ESPRIT Study Group (2006) Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): Randomised controlled trial. Lancet 367: 1665-1673
3. Diener HC et al. (1996) European Stroke Prevention Study 2: Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 143: 1-13
4. Gould KL et al. (1978) Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatation II: Clinical methodology and feasibility. Am J Cardiol 41: 279-287
5. Tsuya T et al. (1990) Effect of dipyridamole at the usual oral dose on exercise-induced myocardial ischemia in stable angina pectoris. Am J Cardiol 66: 275-278
6. Klimt CR et al. (1986) Persantine-Aspirin Reinfarction Study part II: Secondary coronary prevention with persantine and aspirin. J Am Coll Cardiol 7: 251-269
7. Albers GW (2000) Choice of endpoints in antiplatelet trials: Which outcomes are most relevant to stroke patients? Neurology 54: 1022-1028
8. Diener HC et al. (2001) Cardiac safety in the European Stroke Prevention Study 2 (ESPS2). Int J Clin Pract 55: 162-163
9. Gibbons RJ et al. (2003) ACC/AHA 2002 guideline update for the management of patients with chronic stable angina - summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation 107: 149-158
10. Tran H and Anand SS (2004) Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease. JAMA 292: 1867-1874